Allurion Technologies, Inc. (ALUR): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$77.19M
As of 2025-12-31
-$77.91M
As of 2026-03-31
2022-12-31: -$32.31M2023-12-31: -$71.30M2024-03-31: -$66.16M2024-06-30: -$70.58M2024-09-30: -$64.79M2024-12-31: -$77.98M2025-12-31: -$77.19M-$77.19M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$77.19Mn/m2026-03-30, Balance as of period end
2024-12-31-$77.98Mn/a2026-03-30, Balance as of period end
2024-09-30-$64.79Mn/a2025-08-19, Balance as of period end
2024-06-30-$70.58Mn/a2025-08-19, Balance as of period end
2024-03-31-$66.16Mn/a2025-08-19, Balance as of period end
2023-12-31-$71.30Mn/m2025-08-28, Balance as of period end
2022-12-31-$32.31Mn/a2025-08-28, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Allurion Technologies, Inc. (ALUR)2025-12-31-$77.19Mn/m
Biotricity Inc. (BTCY)2026-03-31-$34.68Mn/m
Profound Medical Corp. (PROF)2025-12-31$66.43M+10.0%
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$1.49Mn/m
Nephros Inc (NEPH)2025-12-31$10.20M+18.8%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$3.10M-29.8%
Spectral AI, Inc. (MDAI)2025-12-31-$5.73Mn/m
Nexgel, Inc. (NXGL)2025-12-31$4.46M-22.5%
DarioHealth Corp. (DRIO)2025-12-31$67.92M-5.7%

Compare ALUR, BTCY, PROF, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗